• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Van der Weijst, L.
    Aguado-Barrera, M. E.
    Azria, D.
    Berkovic, P.
    Boisselier, P.
    Briers, E.
    Bultijnck, R.
    Calvo-Crespo, P.
    Chang-Claude, J.
    Choudhury, A.
    Defraene, G.
    Demontois, S.
    Dunning, A. M.
    Elliott, R. M.
    Ennis, D.
    Faivre-Finn, C.
    Franceschini, M.
    Gutiérrez-Enríquez, S.
    Herskind, C.
    Higginson, D. S.
    Kerns, S. L.
    Johnson, K.
    Mollà, M.
    Lambrecht, M.
    Ramos, M.
    Rancati, T.
    Rimner, A.
    Rosenstein, B. S.
    De Ruysscher, D.
    Salem, A.
    Sangalli, C.
    Seibold, P.
    Sosa-Fajardo, P.
    Sperk, E.
    Stobart, H.
    Summersgill, H.
    Surmont, V.
    Symonds, P.
    Taboada-Lorenzo, B.
    Talbot, C. J.
    Valdagni, R.
    Vega, A.
    Veldeman, L.
    Veldwijk, M. R.
    Ward, T.
    Webb, A.
    West, C. M. L.
    Lievens, Y.
    Show allShow less
    Issue Date
    2022
    
    Metadata
    Show full item record
    Abstract
    Objectives Radiotherapy-induced toxicity may negatively impact health-related quality of life (HRQoL). This report investigates the impact of curative-intent radiotherapy on HRQoL and toxicity in early stage and locally-advanced non-small cell lung cancer patients treated with radiotherapy or chemo-radiotherapy enrolled in the observational prospective REQUITE study. Materials and methods HRQoL was assessed using the European Organisation for Research and Treatment of Cancer QLQ-C30 questionnaire up to 2 years post radiotherapy. Eleven toxicities were scored by clinicians using the Common Terminology Criteria for Adverse Events (CTCAE) version 4. Toxicity scores were calculated by subtracting baseline values. Mixed model analyses were applied to determine statistical significance (p ≤ 0.01). Meaningful clinical important differences (MCID) were determined for changes in HRQoL. Analysis was performed on the overall data, different radiotherapy techniques, multimodality treatments and disease stages. Results Data of 510 patients were analysed. There was no significant change in HRQoL or its domains, except for deterioration in cognitive functioning (p = 0.01). Radiotherapy technique had no significant impact on HRQoL. The addition of chemotherapy was significantly associated with HRQoL over time (p <.001). Overall toxicity did not significantly change over time. Acute toxicities of radiation-dermatitis (p =.003), dysphagia (p =.002) and esophagitis (p <.001) peaked at 3 months and decreased thereafter. Pneumonitis initially deteriorated but improved significantly after 12 months (p =.011). A proportion of patients experienced meaningful clinically important improvements and deteriorations in overall HRQoL and its domains. In some patients, pre-treatment symptoms improved gradually. Conclusions While overall HRQoL and toxicity did not change over time, some patients improved, whereas others experienced acute radiotherapy-induced toxicities and deteriorated HRQoL, especially physical and cognitive functioning. Patient characteristics, more so than radiotherapy technique and treatment modality, impact post-radiotherapy toxicity and HRQoL outcomes. This stresses the importance of considering the potential impact of radiotherapy on individuals’ HRQoL, symptoms and toxicity in treatment decision-making.
    Citation
    Van der Weijst L, Aguado-Barrera ME, Azria D, Berkovic P, Boisselier P, Briers E, et al. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study). Vol. 166, Lung Cancer. Elsevier BV; 2022. p. 228–41.
    Journal
    Lung Cancer
    URI
    http://hdl.handle.net/10541/625174
    DOI
    10.1016/j.lungcan.2022.03.010
    PubMed ID
    35334417
    Additional Links
    https://dx.doi.org/10.1016/j.lungcan.2022.03.010
    Type
    Article
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.lungcan.2022.03.010
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Real Life Data on Patient-Reported Outcomes and Neuro-Cognitive Functioning of Lung Cancer Patients: The PRO-Long Study.
    • Authors: Van Der Weijst L, Surmont V, Schrauwen W, Lievens Y
    • Issue date: 2021
    • Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.
    • Authors: Auchter RM, Scholtens D, Adak S, Wagner H, Cella DF, Mehta MP
    • Issue date: 2001 Aug 1
    • Health-related quality of life in long-term survivors of unresectable locally advanced non-small cell lung cancer.
    • Authors: Ran J, Wang J, Bi N, Jiang W, Zhou Z, Hui Z, Liang J, Feng Q, Wang L
    • Issue date: 2017 Dec 2
    • Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
    • Authors: Sztankay M, Giesinger JM, Zabernigg A, Krempler E, Pall G, Hilbe W, Burghuber O, Hochmair M, Rumpold G, Doering S, Holzner B
    • Issue date: 2017 Aug 23
    • Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy.
    • Authors: Hong F, Bosco JL, Bush N, Berry DL
    • Issue date: 2013 Mar 28
    DSpace software (copyright © 2002 - 2022)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.